SH PHARMA Reports Stable Share Capital for March 2026; Public Float Fully Compliant

Bulletin Express04-02

Shanghai Pharmaceuticals Holding Co., Ltd. (SH PHARMA) submitted its Monthly Return for the period ended 31 March 2026, indicating zero changes in authorised, issued or treasury shares during the month.

Total authorised share capital remained at 3.71 billion ordinary shares with a par value of RMB 1.00 each, comprising 919.07 million H shares listed in Hong Kong and 2.79 billion A shares listed in Shanghai. Issued share counts matched these authorised figures, confirming no new share issues, cancellations or repurchases.

The company held no treasury shares and affirmed compliance with the Hong Kong Stock Exchange’s 5% minimum public-float requirement for its H-share class.

Employee incentives also stayed unchanged: 0.68 million A-share options, carrying an exercise price of RMB 20.16, remained outstanding, with no exercises and therefore no capital inflow during March.

SH PHARMA reported no outstanding warrants, convertible securities or other equity-linked arrangements for the month.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1105340398?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-04-02 18:05","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1105340398","market":"hk","top_or_hot":-1,"title":"SH PHARMA Reports Stable Share Capital for March 2026; Public Float Fully Compliant","media":"Bulletin Express","content":"<p>Shanghai Pharmaceuticals Holding Co., Ltd. (SH PHARMA) submitted its Monthly Return for the period ended 31 March 2026, indicating zero changes in authorised, issued or treasury shares during the month.</p>\n<p>Total authorised share capital remained at 3.71 billion ordinary shares with a par value of RMB 1.00 each, comprising 919.07 million H shares listed in Hong Kong and 2.79 billion A shares listed in Shanghai. Issued share counts matched these authorised figures, confirming no new share issues, cancellations or repurchases.</p>\n<p>The company held no treasury shares and affirmed compliance with the Hong Kong Stock Exchange’s 5% minimum public-float requirement for its H-share class.</p>\n<p>Employee incentives also stayed unchanged: 0.68 million A-share options, carrying an exercise price of RMB 20.16, remained outstanding, with no exercises and therefore no capital inflow during March.</p>\n<p>SH PHARMA reported no outstanding warrants, convertible securities or other equity-linked arrangements for the month.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>SH PHARMA Reports Stable Share Capital for March 2026; Public Float Fully Compliant</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSH PHARMA Reports Stable Share Capital for March 2026; Public Float Fully Compliant\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-04-02 18:05</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shanghai Pharmaceuticals Holding Co., Ltd. (SH PHARMA) submitted its Monthly Return for the period ended 31 March 2026, indicating zero changes in authorised, issued or treasury shares during the month.</p>\n<p>Total authorised share capital remained at 3.71 billion ordinary shares with a par value of RMB 1.00 each, comprising 919.07 million H shares listed in Hong Kong and 2.79 billion A shares listed in Shanghai. Issued share counts matched these authorised figures, confirming no new share issues, cancellations or repurchases.</p>\n<p>The company held no treasury shares and affirmed compliance with the Hong Kong Stock Exchange’s 5% minimum public-float requirement for its H-share class.</p>\n<p>Employee incentives also stayed unchanged: 0.68 million A-share options, carrying an exercise price of RMB 20.16, remained outstanding, with no exercises and therefore no capital inflow during March.</p>\n<p>SH PHARMA reported no outstanding warrants, convertible securities or other equity-linked arrangements for the month.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02607","symbol_name":"上海医药","start_time":0,"source_url":"","article_id":"1105340398","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1105340398","pubTimestamp":1775124339,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Shanghai Pharmaceuticals Holding Co., Ltd. (SH PHARMA) submitted its Monthly Return for the period ended 31 March 2026, indicating zero changes in authorised, issued or treasury shares during the...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02607":"上海医药"},"translate_title":"上海医药报告2026年3月股本稳定；公众持股量完全合规","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02607":1},"content_text":"Shanghai Pharmaceuticals Holding Co., Ltd. (SH PHARMA) submitted its Monthly Return for the period ended 31 March 2026, indicating zero changes in authorised, issued or treasury shares during the month.\nTotal authorised share capital remained at 3.71 billion ordinary shares with a par value of RMB 1.00 each, comprising 919.07 million H shares listed in Hong Kong and 2.79 billion A shares listed in Shanghai. Issued share counts matched these authorised figures, confirming no new share issues, cancellations or repurchases.\nThe company held no treasury shares and affirmed compliance with the Hong Kong Stock Exchange’s 5% minimum public-float requirement for its H-share class.\nEmployee incentives also stayed unchanged: 0.68 million A-share options, carrying an exercise price of RMB 20.16, remained outstanding, with no exercises and therefore no capital inflow during March.\nSH PHARMA reported no outstanding warrants, convertible securities or other equity-linked arrangements for the month.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"shareholding,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1105340398","isCrawlerRequest":true}